|
Normal
|
Disease state |
|
|
None
|
Compound treatment |
|
|
Stromal cell
|
Cell type |
|
|
Primary
|
Disease staging |
|
|
Epithelial cell
|
Cell type |
|
|
Peripheral blood
|
Organism part |
|
|
Fibroblast
|
Cell type |
|
|
HeLa
|
Cell line |
|
|
HL-60
|
Cell line |
|
|
Caco-2
|
Cell line |
|
|
PC3
|
Cell line |
|
|
Macaca mulatta
|
Organism |
|
|
Kidney
|
Organism part |
|
|
FLAP
|
Compound treatment |
|
|
Homo sapiens
|
Organism |
|
|
Breast carcinoma
|
Disease state |
|
|
Lymph node metastasis
|
Disease staging |
|
|
Not applicable
|
Histology |
|
|
Monocyte
|
Cell type |
|
|
HNRPA2B
|
Compound treatment |
|
|
Liver
|
Organism part |
|
|
MK886
|
Compound treatment |
|
|
Cystic change
|
Histology |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
Heart
|
Organism part |
|
|
Blood
|
Organism part |
|
|
Tonsil
|
Organism part |
|
|
Skeletal muscle
|
Organism part |
|
|
Uninfected
|
Infection |
|
|
ERalpha transfected
|
Genotype |
|
|
ERbeta transfected
|
Genotype |
|
|
Prostate cancer
|
Disease state |
|
|
Endothelial cell
|
Cell type |
|
|
Acute myeloid leukemia
|
Disease state |
|
|
Cerebellum
|
Organism part |
|
|
Chronic lymphocytic leukemia
|
Disease state |
|
|
Alveolar space neutrophil
|
Cell type |
|
|
Unknown_sex
|
Sex |
|
|
IgV status unknown
|
Genotype |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
Tumor
|
Organism part |
|
|
T84
|
Cell line |
|
|
Beas2B
|
Cell line |
|
|
Primary gastric tumor
|
Organism part |
|
|
Malignant melanoma
|
Disease state |
|
|
A549
|
Cell line |
|
|
Circulating neutrophil
|
Cell type |
|
|
Granulocyte macrophage-colony ...
|
Compound treatment |
|
|
Female
|
Sex |
|
|
IgV mutated
|
Genotype |
|
|
IgV unmutated
|
Genotype |
|
|
Male
|
Sex |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
MCF7
|
Cell line |
|
|
P53 knockdown
|
RNAi |
|
|
Glioblastoma
|
Disease state |
|
|
Acute radiation toxicity
|
Clinical history |
|
|
ATM knockdown
|
RNAi |
|
|
Epilepsy
|
Disease state |
|
|
Pan troglodytes
|
Organism |
|
|
Testicular seminoma
|
Disease state |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
Caudate nucleus
|
Organism part |
|
|
Grade IV
|
Tumor grading |
|
|
Keratinocyte
|
Cell type |
|
|
Uninfected control
|
RNAi |
|
|
Differentiated
|
Cell type |
|
|
Naive
|
Cell type |
|
|
Cigarette smoke
|
Growth condition |
|
|
Incubator control
|
Growth condition |
|
|
SM1
|
Cell line |
|
|
Astrocyte
|
Cell type |
|
|
HPL1
|
Cell line |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
Primary blood vessel endotheli...
|
Cell type |
|
|
Enzo Labeling
|
Protocol type |
|
|
MDA-MB-231
|
Cell line |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
CD34+
|
Cell type |
|
|
Neuroblastoma cell
|
Cell type |
|
|
HaCaT
|
Cell line |
|
|
Metastatic
|
Disease staging |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Control
|
Compound treatment |
|
|
Primary lymphatic endothelial ...
|
Cell type |
|
|
Placebo
|
Compound treatment |
|
|
Glutamine
|
Compound treatment |
|
|
Cigarette smoke
|
Compound treatment |
|
|
Duchenne muscular dystrophy
|
Disease state |
|
|
Trichostatin A
|
Compound treatment |
|
|
CodeLink Labeling
|
Protocol type |
|
|
MCF10A
|
Cell line |
|
|
Epidermal keratinocyte
|
Cell type |
|
|
SkinEthic keratinocyte
|
Cell type |
|
|
Kaposi's sarcoma
|
Disease state |
|
|
White blood cells
|
Organism part |
|
|
Ischemic cardiomyopathy
|
Disease state |
|
|
In vitro neutrophil
|
Cell type |
|
|
LacZ control
|
RNAi |
|
|
Crohn's disease
|
Disease state |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
Limited radiation toxicity
|
Clinical history |
|
|
Benign nevi
|
Disease state |
|
|
Serum starvation synchronizati...
|
Growth condition |
|
|
Benign
|
Disease staging |
|
|
Heat-killed HL60 cell lysate
|
Infection |
|
|
MKN28
|
Cell line |
|
|
IM95
|
Cell line |
|
|
BC-3
|
Cell line |
|
|
Adrenal cortex cell
|
Cell type |
|
|
N/a
|
Test result |
|
|
Fetal bovine serum in media
|
Growth condition |
|
|
Native skin
|
Cell type |
|
|
Serum starvation + thymidine b...
|
Growth condition |
|
|
Lung adenocarcinoma
|
Disease state |
|
|
Plasma cell
|
Cell type |
|
|
B lymphocyte
|
Cell type |
|
|
Chondrocyte
|
Cell type |
|
|
Molecular class type 1
|
Test result |
|
|
Molecular class type 2
|
Test result |
|
|
Term
|
Developmental stage |
|
|
Midgestation
|
Developmental stage |
|
|
Lymph node
|
Organism part |
|
|
Met5A
|
Cell line |
|
|
5-aza-2'-deoxycytidine
|
Compound treatment |
|
|
Baseline uninfected
|
Disease state |
|
|
U937
|
Cell line |
|
|
Acute lymphocytic leukemia
|
Disease state |
|
|
Synovial fluid
|
Organism part |
|
|
X-linked chronic granulomatous
|
Disease state |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
Neutrophil
|
Cell type |
|
|
Johnsen score count 5: no sper...
|
Histology |
|
|
CD16+ dendritic cell
|
Cell type |
|
|
Clear cell sarcoma of the kidn...
|
Disease state |
|
|
BT474
|
Cell line |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
Smooth muscle
|
Organism part |
|
|
BJAB
|
Cell line |
|
|
721 B lymphoblast
|
Cell type |
|
|
Papillary thyroid carcinoma
|
Disease state |
|
|
SKMEL5
|
Cell line |
|
|
T cell
|
Cell type |
|
|
Peripheral blood mononuclear c...
|
Cell type |
|
|
CD3int CD4+ CD8+
|
Phenotype |
|
|
Double positive thymocyte
|
Cell type |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
Type 2B
|
Histology |
|
|
Methotrexate
|
Compound treatment |
|
|
Cyclophosphamide resistant
|
Phenotype |
|
|
Cyclophosphamide senstive
|
Phenotype |
|
|
Tumor cell
|
Cell type |
|
|
PT1
|
Disease staging |
|
|
Skin
|
Organism part |
|
|
PT3
|
Disease staging |
|
|
CD8+ T cell
|
Cell type |
|
|
Carcinoma in situ lesion
|
Disease state |
|
|
SsMCF7
|
Cell line |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
HGF stimulation
|
Growth condition |
|
|
293
|
Cell line |
|
|
Idiopathic dilated cardiomyopa...
|
Disease state |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
Superior cervical ganglion
|
Organism part |
|
|
BC-5
|
Cell line |
|
|
GLI56
|
Cell line |
|
|
Dimethyl sulfoxide
|
Compound treatment |
|
|
2-(3,4,5-trimethoxy-phenylamin...
|
Compound treatment |
|
|
ITM-E6E7
|
Cell line |
|
|
Endometrioid carcinoma
|
Disease state |
|
|
Capra hircus
|
Organism |
|
|
Cervical cancer
|
Disease state |
|
|
Skin substitute
|
Cell type |
|
|
Estrogen receptor 1 negative; ...
|
Test result |
|
|
PT2
|
Disease staging |
|
|
Immortalized endothelial cell
|
Cell type |
|
|
Macrophage
|
Cell type |
|
|
Dendritic cell
|
Cell type |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
ITM-ST
|
Cell line |
|
|
Secretory cell
|
Cell type |
|
|
MiR15a/miR16-1 transfection
|
Gene modification |
|
|
Geriatric
|
Developmental stage |
|
|
Pediatric
|
Developmental stage |
|
|
Filtered air
|
Compound treatment |
|
|
Adult
|
Developmental stage |
|
|
Infant
|
Developmental stage |
|
|
Burkitt's lymphoma
|
Disease state |
|
|
Oligodendroglioma
|
Disease state |
|
|
Differentiated
|
Developmental stage |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Vanadium pentoxide
|
Compound treatment |
|
|
KSHV infection
|
Disease state |
|
|
Normal
|
Histology |
|
|
Seminiferous tubule
|
Organism part |
|
|
High-stage neuroblastoma
|
Disease state |
|
|
KSHV latent infection
|
Disease state |
|
|
Primary bone marrow CD34+ stem...
|
Cell type |
|
|
Muscle invasive carcinoma
|
Disease state |
|
|
Pongo pygmaea
|
Organism |
|
|
RelA knockdown
|
RNAi |
|
|
Psoriatic lesional biopsy
|
Clinical info |
|
|
Uninvolved biopsy
|
Clinical info |
|
|
CD11c+ dendritic cell
|
Cell type |
|
|
Sporadic basal-like breast can...
|
Disease state |
|
|
T1bN0M0
|
Disease staging |
|
|
Johnsen score count 10: full s...
|
Histology |
|
|
GLI60
|
Cell line |
|
|
Multiple myeloma
|
Disease state |
|
|
Control - keratinocyte growth ...
|
Compound treatment |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
Immediately after exercise
|
Clinical info |
|
|
BDCA1+ dendritic cell
|
Cell type |
|
|
Pancreatic cancer
|
Disease state |
|
|
Vasectomized
|
Clinical history |
|
|
Pan paniscus
|
Organism |
|
|
Cartilage
|
Organism part |
|
|
Cancer1
|
Replicate |
|
|
Gastric cancer
|
Disease state |
|
|
Granulocyte-colony stimulating...
|
Compound treatment |
|
|
Uterine cervix
|
Organism part |
|
|
Prostate
|
Organism part |
|
|
Affymetrix Labeling
|
Protocol type |
|
|
PCep4 control vector transfect...
|
Gene modification |
|
|
ETat plasmid transfection
|
Gene modification |
|
|
BC-1
|
Cell line |
|
|
Senescence bypassed
|
Phenotype |
|
|
Pergolide methanesulfonate
|
Compound treatment |
|
|
CD19+ B-cell
|
Cell type |
|
|
CD3+ CD4+ CD8- CD45RA+ CD62L+
|
Phenotype |
|
|
Naive T cell
|
Cell type |
|
|
ITV
|
Cell line |
|
|
Normal
|
Clinical history |
|
|
Ethanol
|
Compound treatment |
|
|
Ponasterone A
|
Compound treatment |
|
|
Experimental malaria-infected
|
Disease state |
|
|
CD3high CD4+ CD8-
|
Phenotype |
|
|
Single positive thymocyte
|
Cell type |
|
|
Vitamin E
|
Compound treatment |
|
|
Uninduced
|
Growth condition |
|
|
Measles virus Chicago-1 strain
|
Infection |
|
|
None
|
Gene modification |
|
|
YCC3
|
Cell line |
|
|
ITM-E6E7-ST
|
Cell line |
|
|
Breast cancer
|
Disease state |
|
|
Lin- CD34-
|
Phenotype |
|
|
IMP(1,3)B
|
RNAi |
|
|
Lung
|
Organism part |
|
|
Vulvar intraepithelial neoplas...
|
Disease state |
|
|
Hydrogen peroxide
|
Compound treatment |
|
|
Nocodazole
|
Compound treatment |
|
|
Stroma from endometriotic nodu...
|
Organism part |
|
|
Inter-prandial lipid micelles ...
|
Growth condition |
|
|
Bronchial epithelial cell
|
Cell type |
|
|
Postprandial lipid micelles in...
|
Growth condition |
|
|
ITS medium
|
Growth condition |
|
|
HMEC184
|
Cell line |
|
|
Adrenal gland
|
Organism part |
|
|
ITS medium with albumin-bound ...
|
Growth condition |
|
|
Neuroblastoma
|
Disease state |
|
|
Ewing family tumor
|
Disease state |
|
|
Low-stage neuroblastoma
|
Disease state |
|
|
Obesity
|
Disease state |
|
|
CD4+ T-cell
|
Cell type |
|
|
Mesenchymal stem cell
|
Cell type |
|
|
T-cell acute lymphoblastic leu...
|
Disease state |
|
|
Head and neck squamous cell ca...
|
Disease state |
|
|
5-aza-2'-deoxycytidine + trich...
|
Compound treatment |
|
|
T47D
|
Cell line |
|
|
MDS-associated acute myeloid l...
|
Disease state |
|
|
Bone marrow
|
Organism part |
|
|
CD14+ monocyte
|
Cell type |
|
|
Relapse 1; ER status ER+; brai...
|
Clinical info |
|
|
IL-22
|
Compound treatment |
|
|
JMN1B
|
Cell line |
|
|
Dermatomyositis
|
Disease state |
|
|
Empty vector
|
Gene modification |
|
|
MSTO-211H
|
Cell line |
|
|
ERalpha L540Q transfected
|
Genotype |
|
|
Ovary
|
Organism part |
|
|
H1334
|
Cell line |
|
|
Chronic myelogenous leukemia
|
Disease state |
|
|
Naive CD4 T cell
|
Target cell type |
|
|
Granulocyte
|
Cell type |
|
|
Grade III
|
Tumor grading |
|
|
Cornea epithelium
|
Organism part |
|
|
Conjunctival epithelium
|
Organism part |
|
|
Intraepithelium
|
Organism part |
|
|
A=2 and B=1
|
Test result |
|
|
BCBL-1
|
Cell line |
|
|
IBL4
|
Cell line |
|
|
Permanent atrial fibrillation
|
Disease state |
|
|
No atrial fibrillation
|
Disease state |
|
|
None
|
Infection |
|
|
Current smoker
|
Clinical info |
|
|
Primary smooth muscle cell
|
Cell type |
|
|
Toxoplasma gondii
|
Infection |
|
|
T3aNxMx
|
Disease staging |
|
|
G3
|
Tumor grading |
|
|
KSHV-positive EBV-positive
|
Clinical info |
|
|
Mutant fumarate hydratase
|
Genotype |
|
|
KSHV-negative EBV-positive
|
Clinical info |
|
|
Estrogen receptor 1 negative; ...
|
Test result |
|
|
Non-ischemic cardiomyopathy
|
Disease state |
|
|
Daudi Burkitt's lymphoma
|
Disease state |
|